7Baggers
 IO Biotech (IOBT) Downgraded to Hold by TD Cowen | IOBT Stock Ne  GuruFocus Tue, 30 Sep 2025 15:48:48 GMT
 IO Biotech Feels The Heat As US FDA Dashes Cylembio Filing Hopes  insights.citeline.com Tue, 30 Sep 2025 15:02:56 GMT
 TD Cowen Maintains IO Biotech(IOBT.US) With Hold Rating  富途牛牛 Tue, 30 Sep 2025 13:31:00 GMT
 TD Cowen Downgrades IO Biotech to Hold From Buy  MarketScreener Tue, 30 Sep 2025 12:16:37 GMT
 FDA Recommends Against IO Biotech’s Cylembio Application  The Globe and Mail Tue, 30 Sep 2025 11:54:00 GMT
 IO Biotech downgraded to Hold from Buy at TD Cowen  TipRanks Tue, 30 Sep 2025 09:10:21 GMT
 FDA rejection prompts IO Biotech to cut workforce by 50%  medwatch.com Tue, 30 Sep 2025 09:07:00 GMT
 td cowen downgrades io biotech(iobt.us) to hold rating  富途牛牛 Tue, 30 Sep 2025 05:28:56 GMT
 io biotech stock rating downgraded to hold by td cowen on fda setback  Investing.com Canada Tue, 30 Sep 2025 04:45:59 GMT
 IO Biotech stock rating downgraded to Hold by TD Cowen on FDA setback  Investing.com Australia Mon, 29 Sep 2025 22:13:05 GMT
 IO Biotech stock downgraded to Neutral by H.C. Wainwright on trial delays  Investing.com Nigeria Mon, 29 Sep 2025 17:38:29 GMT
 IO Biotech sheds 50% of jobs after cancer vaccine plan hits FDA wall  FirstWord Pharma Mon, 29 Sep 2025 16:33:29 GMT
 H.C. Wainwright Downgrades IO Biotech(IOBT.US) to Hold Rating  富途牛牛 Mon, 29 Sep 2025 16:31:00 GMT
 IO Biotech stock plummets after FDA recommends against BLA submission By Investing.com  Investing.com South Africa Mon, 29 Sep 2025 14:57:18 GMT
 nasdaq jumps 150 points; us pending home sales rise  Benzinga Mon, 29 Sep 2025 14:11:58 GMT
 io lays off 50% after fda derails cancer vaccine approval plan  Fierce Biotech Mon, 29 Sep 2025 12:55:00 GMT
 FDA Recommends Against IO Biotech’s Cylembio Application  TipRanks Mon, 29 Sep 2025 12:02:07 GMT
 FDA recommends against IO Biotech’s BLA for melanoma vaccine By Investing.com  Investing.com Australia Mon, 29 Sep 2025 11:57:39 GMT
 IO Biotech provides update following pre-BLA meeting with FDA  MarketScreener Mon, 29 Sep 2025 11:13:01 GMT
 IO Biotech to present phase 3 melanoma vaccine data at ESMO  Investing.com Nigeria Wed, 24 Sep 2025 10:11:16 GMT
 io biotech to present phase 3 melanoma vaccine data at esmo  Investing.com Australia Tue, 23 Sep 2025 18:50:41 GMT
 published on: 2025-09-16 18:32:14  خودرو بانک Tue, 16 Sep 2025 15:05:56 GMT
 td cowen maintains io biotech(iobt.us) with buy rating  富途牛牛 Wed, 10 Sep 2025 08:19:12 GMT
 td cowen maintains io biotech(iobt.us) with buy rating  富途牛牛 Tue, 09 Sep 2025 07:00:00 GMT
 io biotech’s vaccine misses on mpfs in phase iii advanced melanoma trial  The Cancer Letter Fri, 05 Sep 2025 19:48:17 GMT
 IO Biotech Announces Participation in Upcoming Investor Conferences  Yahoo Finance Thu, 04 Sep 2025 07:00:00 GMT
 IO Biotech, Inc. (IOBT) Upgraded to Buy: Here's What You Should Know  Yahoo Finance Wed, 03 Sep 2025 07:00:00 GMT
 published on: 2025-09-01 11:29:35  Newser Mon, 01 Sep 2025 16:29:35 GMT
 published on: 2025-09-01 00:18:30  Newser Mon, 01 Sep 2025 05:18:30 GMT
 published on: 2025-08-31 05:53:00  Newser Sun, 31 Aug 2025 10:53:00 GMT
 published on: 2025-08-30 22:57:33  Newser Sun, 31 Aug 2025 03:57:33 GMT
 published on: 2025-08-30 22:42:04  Newser Sun, 31 Aug 2025 03:42:04 GMT
 published on: 2025-08-30 13:17:53  Newser Sat, 30 Aug 2025 18:17:53 GMT
 published on: 2025-08-29 06:43:29  Newser Fri, 29 Aug 2025 11:43:29 GMT
 is iobt a good stock to consider?  AInvest Wed, 27 Aug 2025 17:21:10 GMT
 published on: 2025-08-27 06:35:20  Newser Wed, 27 Aug 2025 11:35:20 GMT

IO Biotech, Inc.
(NASDAQ:IOBT) 

IOBT stock logo

IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops disruptive immune modulating anti-cancer therapies in Denmark. The company's lead product candidate, IO102-IO103, is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death...

Founded: 2014
CEO / Founder: Mai-Britt Zocca 
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends